Search Results

Filter
  • 1-10 of  22,610 results for ""Neoplasms radiotherapy""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Heterogeneous intratumor irradiation: a new partner for immunotherapy.

  • Authors : Bergeron P; INSERM U1030, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Milliat F

Subjects: Immunotherapy*/Immunotherapy*/Immunotherapy*/methods; Animals ; Humans

  • Source: Oncoimmunology [Oncoimmunology] 2024 Dec 31; Vol. 13 (1), pp. 2434280. Date of Electronic Publication: 2024 Nov 26.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

RIPK1 inhibition in malignant cells potentiates immunotherapy and radiotherapy outcome.

  • Authors : Pol JG; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France.

Subjects: Receptor-Interacting Protein Serine-Threonine Kinases*/Receptor-Interacting Protein Serine-Threonine Kinases*/Receptor-Interacting Protein Serine-Threonine Kinases*/metabolism ; Receptor-Interacting Protein Serine-Threonine Kinases*/Receptor-Interacting Protein Serine-Threonine Kinases*/Receptor-Interacting Protein Serine-Threonine Kinases*/antagonists & inhibitors ; Immunotherapy*/Immunotherapy*/Immunotherapy*/methods

  • Source: Oncoimmunology [Oncoimmunology] 2024 Dec 31; Vol. 13 (1), pp. 2425465. Date of Electronic Publication: 2024 Nov 04.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Dose optimization of extended collimators in boron neutron capture therapy.

  • Authors : Zhu Y; Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, People's Republic of China.; University of Science and Technology of China, Hefei 230026, People's Republic of China.

Subjects: Boron Neutron Capture Therapy*/Boron Neutron Capture Therapy*/Boron Neutron Capture Therapy*/methods ; Boron Neutron Capture Therapy*/Boron Neutron Capture Therapy*/Boron Neutron Capture Therapy*/instrumentation ; Monte Carlo Method*

  • Source: Biomedical physics & engineering express [Biomed Phys Eng Express] 2024 Dec 20; Vol. 11 (1). Date of Electronic Publication: 2024 Dec 20.Publisher: IOP Publishing Ltd Country of Publication: England NLM ID: 101675002 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Development and evaluation of a single domain antibody targeting folate receptor alpha for radioligand therapy.

  • Authors : Dewulf J; Precirix, Burg. Etienne Demunterlaan 3, Brussels, Matthias, B-1090, Belgium.; Massa S

Subjects: Single-Domain Antibodies*/Single-Domain Antibodies*/Single-Domain Antibodies*/pharmacology ; Single-Domain Antibodies*/Single-Domain Antibodies*/Single-Domain Antibodies*/chemistry ; Folate Receptor 1*/Folate Receptor 1*/Folate Receptor 1*/metabolism

  • Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Dec 19; Vol. 22 (1), pp. 763. Date of Electronic Publication: 2024 Dec 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

Record details

×
Academic Journal

Cancer-associated fibroblasts, tumor and radiotherapy: interactions in the tumor micro-environment.

  • Authors : Raaijmakers KTPM; Radiotherapy and OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Adema GJ

Subjects: Cancer-Associated Fibroblasts*/Cancer-Associated Fibroblasts*/Cancer-Associated Fibroblasts*/metabolism ; Cancer-Associated Fibroblasts*/Cancer-Associated Fibroblasts*/Cancer-Associated Fibroblasts*/pathology ; Cancer-Associated Fibroblasts*/Cancer-Associated Fibroblasts*/Cancer-Associated Fibroblasts*/radiation effects

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Dec 19; Vol. 43 (1), pp. 323. Date of Electronic Publication: 2024 Dec 19.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

Record details

×
Academic Journal

Metabolizable alloy clusters assemble nanoinhibitor for enhanced radiotherapy of tumor by hypoxia alleviation and intracellular PD-L1 restraint.

  • Authors : Ding G; NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Chang Chun, 130021, China.; Liu S

Subjects: B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism; Animals ; Mice

  • Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Dec 19; Vol. 22 (1), pp. 774. Date of Electronic Publication: 2024 Dec 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

Record details

×
Academic Journal

Extracellular vesicles role in radio(nuclide)therapy.

  • Authors : Constanzo J; Nuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Université de Montpellier, Équipe Labellisée Ligue Contre le Cancer, 208 rue des apothicaires, 34298 Montpellier, France.; Pouget JP

Subjects: Extracellular Vesicles*/Extracellular Vesicles*/Extracellular Vesicles*/radiation effects ; Extracellular Vesicles*/Extracellular Vesicles*/Extracellular Vesicles*/metabolism ; Neoplasms*/Neoplasms*/Neoplasms*/radiotherapy

  • Source: Journal of radiation research [J Radiat Res] 2024 Dec 16; Vol. 65 (Supplement_1), pp. i6-i14.Publisher: Oxford University Press Country of Publication: England NLM ID: 0376611 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Genomic Biomarkers Predict Response to Combined ATR Inhibition and Radiotherapy.

  • Authors : Schrank BR; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.; Colbert LE

Subjects: Ataxia Telangiectasia Mutated Proteins*/Ataxia Telangiectasia Mutated Proteins*/Ataxia Telangiectasia Mutated Proteins*/antagonists & inhibitors ; Ataxia Telangiectasia Mutated Proteins*/Ataxia Telangiectasia Mutated Proteins*/Ataxia Telangiectasia Mutated Proteins*/genetics ; Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/Protein Kinase Inhibitors*/pharmacology

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Dec 16; Vol. 30 (24), pp. 5505-5507.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Genotype-Directed Synthetic Cytotoxicity of ATR Inhibition with Radiotherapy.

  • Authors : Ng V; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Sinha S

Subjects: Ataxia Telangiectasia Mutated Proteins*/Ataxia Telangiectasia Mutated Proteins*/Ataxia Telangiectasia Mutated Proteins*/antagonists & inhibitors ; Ataxia Telangiectasia Mutated Proteins*/Ataxia Telangiectasia Mutated Proteins*/Ataxia Telangiectasia Mutated Proteins*/genetics ; Genotype*

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Dec 16; Vol. 30 (24), pp. 5643-5656.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Enhancing representativeness of patient-reported outcomes in routine radiation oncology care: a quality improvement protocol to address non-response.

  • Authors : Zeng C; Patient Reported Outcomes, Value and Experience (PROVE) Center, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA .; Harvard Medical School, Boston, Massachusetts, USA.

Subjects: Patient Reported Outcome Measures* ; Quality Improvement* ; Radiation Oncology*/Radiation Oncology*/Radiation Oncology*/standards

  • Source: BMJ open [BMJ Open] 2024 Dec 12; Vol. 14 (12), pp. e097127. Date of Electronic Publication: 2024 Dec 12.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  22,610 results for ""Neoplasms radiotherapy""